Company Encyclopedia
View More
name
NANFANG MEDICAL
603880.SH
Jiangsu Nanfang Medical Co., Ltd. engages in the research and development, production, and sale of transdermal products, medical adhesive tapes and bandages, first aid kits, sports protection products, protective products, and nursing products in China and internationally. The company offers transdermal products, such as plasters, dressings, and bandages; and protective equipment comprising daily protective masks, disposable medical masks, medical surgical masks, medical nitrile examination gloves, and medical examination gloves. It offers medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical eye pads, elastic stretch tapes, corn removal plasters, waterproof adhesive tapes, pain relief patches, kinesiology tapes, surgical tapes, zinc oxide adhesive plasters, and masks, as well as customized products.
340.02 B
603880.SHMarket value -Rank by Market Cap -/-

Financial Score

10/12/2025 Update
D
Health Care SuppliesIndustry
Industry Ranking41/41
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-56.90%E
    • Profit Margin-34.01%E
    • Gross Margin11.79%D
  • Growth ScoreD
    • Revenue YoY1.71%C
    • Net Profit YoY-20.41%D
    • Total Assets YoY-20.46%E
    • Net Assets YoY-43.82%E
  • Cash ScoreD
    • Cash Flow Margin-294.07%D
    • OCF YoY1.71%C
  • Operating ScoreC
    • Turnover0.53C
  • Debt ScoreD
    • Gearing Ratio73.87%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    The medical consumables sector has undergone significant adjustments, with SINOMED hitting the limit down

    The medical consumables sector has undergone significant adjustments, with SINOMED hitting the limit down, and Tianyi Medical, Double Medical, Guoke Hengtai, ZHYL, Jet Bio-Filtration, and NANFANG MEDICAL also following suit

    Zhitong·
    SZ
    301097
    -1.00%
    SZ
    002901
    0.00%
    SH
    688108
    +0.33%
    Zhitong·
    SZ
    301097
    -1.00%
    SZ
    002901
    0.00%
    SH
    688108
    +0.33%

    NANFANG MEDICAL: Net profit loss of 12.9677 million yuan in the first half of 2025

    NANFANG MEDICAL announced that its operating revenue in the first half of 2025 is 306 million yuan, a year-on-year increase of 1.39%. The net profit attributable to shareholders of the listed company is -12.9677 million yuan, compared to 1.0265 million yuan in the same period last year

    Zhitong·
    SH
    603880
    -2.37%
    Zhitong·
    SH
    603880
    -2.37%

    NANFANG MEDICAL: It is expected that the net profit attributable to the owners of the parent company in the first half of the year will be a loss of 12 million to 16 million yuan, turning from profit to loss year-on-year

    NANFANG MEDICAL expects a net loss attributable to the parent company owners of between 12 million and 16 million yuan in the first half of 2025, compared to a profit of 1.0265 million yuan in the same period last year, indicating a shift from profit to loss. During the reporting period, the prices of raw materials for some products increased, leading to higher costs. Additionally, factors such as international trade policies, geopolitical issues, and logistics transportation affected some product orders, significantly impacting revenue and profit

    Zhitong·
    SH
    603880
    -2.37%
    Zhitong·
    SH
    603880
    -2.37%

    Medical device concept stocks continue to rise, Hob Biotech hits the 20% limit up in the afternoon

    Hob Biotech hit a 20CM limit up in the afternoon, NANFANG MEDICAL previously hit a limit up, Kangwei Century, Kangzhong Medical, and Aohua Endoscopy rose over 5%, while Libang Instruments, Chutian Technology, and Baolite also followed suit. On the news front, the National Medical Products Administration reviewed and approved the "Measures to Optimize the Whole Life Cycle Supervision to Support the Innovative Development of High-end Medical Devices," supporting the innovative development of high-end medical devices, and new measures will be introduced

    Zhitong·
    SH
    688656
    +1.47%
    SH
    603880
    -2.37%
    Zhitong·
    SH
    688656
    +1.47%
    SH
    603880
    -2.37%

    The medical device sector saw a short-term surge, with NANFANG MEDICAL hitting the daily limit

    The medical device sector saw a short-term surge, with NANFANG MEDICAL hitting the daily limit, and Hob Biotech, SSSW, Zhengchuan Pharmapack, Rejing Biotech, and Edan all rising

    Zhitong·
    SH
    688399
    -1.49%
    SH
    603976
    -1.14%
    SZ
    300206
    -0.45%
    Zhitong·
    SH
    688399
    -1.49%
    SH
    603976
    -1.14%
    SZ
    300206
    -0.45%
    © 2025 Longbridge｜Disclaimer